BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20932742)

  • 1. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.
    Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M
    Eur J Cancer; 2011 Jan; 47(2):296-304. PubMed ID: 20932742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
    Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
    Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
    Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
    Correale J; Villa A
    J Neuroimmunol; 2008 Mar; 195(1-2):121-34. PubMed ID: 18234356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A; Berg RE; Crossley E; Murray S; Forman J
    Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
    Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
    Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.
    Hodge G; Mukaro V; Holmes M; Reynolds PN; Hodge S
    Respirology; 2013 Feb; 18(2):369-76. PubMed ID: 23062183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
    Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Different responses of CD94/NKG2A-bright and CD94/NKG2A-dim NK cell subsets isolated from patients with multiple sclerosis to interferon-beta].
    Li L; Deng YC; Zhao G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):533-5. PubMed ID: 17553351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
    Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.